Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$2.4M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 3 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 7 most recent Form 4 transactions.
| Aug 7 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 8,000 | $104.38 | $835K | -29.2% | Open the original filing on SEC.gov |
| Aug 7 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 5,000 | $104.47 | $522.4K | -100.0% | Open the original filing on SEC.gov |
| Aug 7 | SYRE | Spyre Therapeutics, Inc. | MEXER◷ | 5,000 | $10.39 | $52K | — | Open the original filing on SEC.gov |
| Jun 24 | KYMR | Kymera Therapeutics, Inc. | AGRANT◆ | 6,068 | — | — | — | Open the original filing on SEC.gov |
| May 27 | SYRE | Spyre Therapeutics, Inc. | AGRANT◆ | 8,026 | — | — | — | Open the original filing on SEC.gov |